Evolus Inc (NAS:EOLS)
$ 13.8 0.97 (7.56%) Market Cap: 873.84 Mil Enterprise Value: 857.25 Mil PE Ratio: 0 PB Ratio: 153.33 GF Score: 56/100

Q3 2021 Evolus Inc Earnings Call Transcript

Nov 02, 2021 / 01:00PM GMT
Release Date Price: $8 (-4.53%)
Operator

Greetings. Welcome to the Evolus Third Quarter 2021 Earnings Conference Call. (Operator Instructions)

Please note that this conference is being recorded. I will now turn the conference over to your host, David Erickson, Vice President of Investor Relations. You may begin.

David Erickson

Thank you, operator, and welcome to everyone joining us on today's call. With me today are David Moatazedi, President and Chief Executive Officer; Lauren Silvernail, Chief Financial Officer and Executive Vice President, Corporate Development; and Rui Avelar, our Chief Medical Officer and Head of Research and Development.

Our prepared remarks today will include forward-looking statements within the meaning of United States securities laws, and management may make additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which may affect the company's business, strategy, operations or financial performance. A detailed discussion of the risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot